Ewing’s Sarcoma of Mandible: Practical Approach to a Challenging Case

Ahmadi, Mohammad Saeid; Sheida, Fateme; Ameri, Ali; Javadinia, Seyed Alireza; Farahani, Farhad; Soltaninia, Omid; Shoar, Leila Moaddab; Pashaki, Abdolazim Sedighi; Gharib, Mohammad Hadi; Abbasi, Rohollah; Amlashi, Zahra Keshtpour

doi:10.1159/000525608

Cited by 5 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, as the multidisciplinary team(MDT) has found its place in medicine ,MDT discussion before the initiation of treatment might be required to formulate the best approach. 32 The current investigation has its limitations, as with all research. Firstly, the patient's social and financial situation may have an impact on their fatigue score, which is outside the researchers' control.…”

Section: Discussionmentioning

confidence: 91%

See 1 more Smart Citation

A Randomized, Controlled, Parallel-Group, Trial on the Long-term Effects of Melatonin on Fatigue Associated With Breast Cancer and Its Adjuvant Treatments

et al. 2023

Self Cite

View full text Add to dashboard Cite

Objective: Cancer related fatigue is a distressing condition and correlated with decrease in quality of life of patients with malignant conditions. In continuation of our previous research, we assessed long term anti-fatigue effects of melatonin in patients with the breast cancer. Material and methods: In this clinical trial, 92 breast cancer patients were randomly assigned to receive either melatonin (18 mg/day) or placebo from 1 week before the adjuvant treatments until 2 years after their completion. The levels of fatigue were assessed before and after intervention using Brief Fatigue Inventory (BFI) and were compared at a significance level of P ≤ .05. Results: The BFI scores were similar between the 2 groups at the baseline (placebo group: 5.56 ± 1.59 and melatonin group: 5.72 ± 1.68, P = .67). After the intervention, not only the mean fatigue score was significantly lower in melatonin group (2.93 ± 1.04 vs 1.99 ± 1.02, P < .001, P ≤ .05), but also a greater reduction in fatigue score in intervention group was evident over time ( P ≤ .001). Conclusion: Long-term usage of melatonin even after completion of adjuvant therapies in women with breast cancer decreased the levels of fatigue associated with the malignant condition and its treatments. The trial registry name and URL, and registration number: Iranian Registry of Clinical Trials, https://en.irct.ir/trial/62267 , IRCT20180426039421N3

show abstract

Section: Discussionmentioning

confidence: 91%

“…Finally, as the multidisciplinary team(MDT) has found its place in medicine, MDT discussion before the initiation of treatment might be required to formulate the best approach. 32…”

Section: Discussionmentioning

confidence: 99%

A Randomized, Controlled, Parallel-Group, Trial on the Long-term Effects of Melatonin on Fatigue Associated With Breast Cancer and Its Adjuvant Treatments

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…Results of isotope scans may also show increased uptake at the site of involvement . Although imaging results indicative of Ewing sarcoma may be similar, distinguishing characteristics of GSO are the acuity of the swelling along with local site discomfort and tenderness . Cortical thickening and periosteal reaction may be seen in a primary bone lymphoma (PBL); however, PBL is uncommon in children younger than 10 years and it is usually accompanied by localized pain and B symptoms (ie, associated with lymphoma) .…”

Section: Discussionmentioning

confidence: 99%

“…2 Although imaging results indicative of Ewing sarcoma may be similar, distinguishing characteristics of GSO are the acuity of the swelling along with local site discomfort and tenderness. 7 Cortical thickening and periosteal reaction may be seen in a primary bone lymphoma (PBL); however, PBL is uncommon in children younger than 10 years and it is usually accompanied by localized pain and B symptoms (ie, associated with lymphoma). 8 Bony expansion and sclerosis may be seen in fibrous dysplasia; however, there will be absence of overlying periosteal reaction, unless there is a pathologic fracture.…”

Section: Discussionmentioning

confidence: 99%